Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France
An observational trial update from France documenting initial hypothyroidism treatment practices without modifying patient care or follow-up…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Effects of L-carnitine on Hypothyroidism [Phase 4]
A Phase 4 clinical trial evaluating the effects of L-carnitine on hypothyroidism has been completed.
-
FDA approval · 2013-11-26FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Levothyroxine sodium (levothyroxine sodium anhydrous) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2013-05-14Clinical Trial Update: Thyroid Study Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 clinical trial update on the Thyroid Study Type 2 Diabetes Mellitus (T2DM) sponsored by Maastricht University Medical Center. The co…
-
FDA label_change · 2013-02-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Levothyroxine Sodium (levothyroxine sodium anhydrous) from Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers [Phase 4]
Phase 4 bioequivalence study comparing two levothyroxine tablet formulations in healthy volunteers.
-
FDA approval · 2012-12-20FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Levothyroxine Sodium (Levothyroxine Sodium Anhydrous) by Fresenius Kabi USA, LLC.
-
FDA approval · 2012-12-14FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental application for LEVOXYL (levothyroxine sodium), resulting in labeling updates for its use in hypothyroidi…
-
CLINICAL_TRIALS other · 2012-12-11Clinical Trial Update: Preconceptional Thyroid Screening and Childhood Nerocognitive Function [NA]
A clinical trial update from Fudan University on preconception thyroid screening and its potential effect on childhood neurocognitive functi…
-
CLINICAL_TRIALS research · 2012-12-07Clinical Trial Update: Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer
A clinical trial update investigating how withdrawing thyroid hormone affects metabolic parameters during radioactive iodine therapy for thy…
-
CLINICAL_TRIALS research · 2012-12-04Clinical Trial Update: Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment [NA]
This document covers a clinical trial comparing desiccated thyroid extract with levothyroxine for treating hypothyroidism. The trial status …
-
FDA approval · 2012-11-29FDA Approved: LIOMNY — Original Application (SIGMAPHARM LABORATORIES, LLC)
FDA approved LIOMNY (liothyronine sodium) from SigmaPharm Laboratories as an original abbreviated new drug application (ANDA) for the treatm…
-
FDA approval · 2012-11-20FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
FDA approved a supplemental application for levothyroxine sodium from Lannett Company, Inc., supporting the generic product's continued mark…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Maternal Hypothyroidism in Pregnancy
This entry notes the completion of a clinical trial investigating maternal hypothyroidism in pregnancy, sponsored by Women and Infants Hospi…
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors [NA]
This terminated clinical trial from MD Anderson investigated combined levothyroxine and liothyronine supplementation in hypothyroid patients…
-
CLINICAL_TRIALS research · 2012-04-25Clinical Trial Update: ThyrOp: A Study of Individual Subclinical Hypothyroidism After Hemithyroidectomy for Benign Nontoxic Goiter
A clinical trial update (NCT01358136) on subclinical hypothyroidism after hemithyroidectomy for benign non-toxic goiter, sponsored by Naestv…
-
FDA approval · 2012-03-04FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) submitted by IBSA Pharma Inc., updating the product labeling…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Maternal Autoimmune Thyroid Disease and Fetal Thyroxin
This entry reports a completed clinical trial from the University of Belgrade investigating maternal autoimmune thyroid disease and fetal th…
-
FDA label_change · 2011-03-21FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
This document notes an FDA supplemental application for LEVOXYL (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc, gene…
-
FDA approval · 2011-03-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
FDA approved the supplemental application for Levothyroxine Sodium from Lannett Company, Inc, authorizing the marketing of this generic prod…
-
FDA approval · 2011-01-14FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for SYNTHROID (levothyroxine sodium) by AbbVie. The approval updates the product under the supplemen…
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism [NA]
This terminated clinical trial evaluated insulin sensitivity and metabolism in patients with hypothyroidism before and after treatment.
-
FDA label_change · 2009-09-01FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA has approved a supplemental application for levothyroxine sodium from Amneal Pharmaceuticals NY LLC, updating labeling and related regul…
-
FDA approval · 2009-09-01FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2009-06-14FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
FDA approved a supplemental application for Levothyroxine Sodium from Lannett Company, Inc., reinforcing the product's existing approval via…